The influence of p53 functions on radiation-induced inflammatory bystander-type signaling in Murine bone marrow

Radiation Research

Volumn 179, Issue 4, 2013, Pages 406-415

  Lorimore, Sally A ^a   Rastogi, Shubhra ^a   Mukherjee, Debayan ^a,b   Coates, Philip J ^a   Wright, Eric G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; FAS LIGAND; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BYSTANDER EFFECT; CANCER CELL; CELL DAMAGE; CELL KILLING; CELL POPULATION; CELL SUSPENSION; CELLS; CHROMOSOME ANALYSIS; CHROMOSOME PREPARATION; CONTROLLED STUDY; DISEASE COURSE; DNA DAMAGE; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION EXPOSURE; RADIATION INJURY; SIGNAL TRANSDUCTION; TOXICITY; TUMOR MICROENVIRONMENT;

ANIMALS; APOPTOSIS; BONE MARROW; BYSTANDER EFFECT; CELLULAR MICROENVIRONMENT; FEMALE; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE; MUS;

EID: 84876273134     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR3158.2     Document Type: Article

References (44)

1. Ron E. Ionizing radiation and cancer risk: evidence from epidemiology. Radiat Res 1998; 150:S30-41.
2. Wakeford R. The cancer epidemiology of radiation. Oncogene 2004; 23:6404-28.
3. Nadeau JH. Modifier genes in mice and humans. Nat Rev Genet 2001; 2:165-74.
4. Ewart-Toland A, Balmain A. The genetics of cancer susceptibility: from mouse to man. Toxicol Pathol 2004; 32(Suppl 1):26-30.
5. Barcellos-Hoff MH, Nguyen DH. Radiation carcinogenesis in context: how do irradiated tissues become tumors? Health Phys 2009; 97:446-57.
6. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation,and cancer. Cell 2010; 140:883-99.
7. Goodhead DT. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol 1994; 65:7-17.
8. Lotem J, Sachs L. Hematopoietic cells from mice deficient in wildtype p53 are more resistant to induction of apoptosis by some agents. Blood 1993; 82:1092-6.
9. Wang L, Cui Y, Lord BI, Roberts SA, Potten CS, Hendry JH, et al. Gamma-ray-induced cell killing and chromosome abnormalities in the bone marrow of p53-deficient mice. Radiat Res 1996; 146:259-66.
10. Silva A, Wyllie A, Collins MK. p53 is not required for regulation of apoptosis or radioprotection by interleukin-3. Blood 1997; 89:2717-22.
11. Lane DP. Cancer. p53, guardian of the genome. Nature 1992; 358:15-6.
12. Little JB. Genomic instability and bystander effects: a historical perspective. Oncogene 2003; 22:6978-87.
13. Lorimore SA, Wright EG. Radiation-induced genomic instability and bystander effects: related inflammatory-type responses to radiation-induced stress and injury? A review. Int J Radiat Biol 2003; 79: 15-25.
14. Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation: I. Radiation-induced genomic instability and bystander effects in vitro. Radiat Res 2003; 159:567-80.
15. Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat Res 2003; 159:581-96.
16. Mothersill C, Seymour C. Radiation-induced bystander effects: past history and future directions. Radiat Res 2001; 155:759-67.
17. Mothersill C, Seymour CB. Radiation-induced bystander effects-implications for cancer. Nat Rev Cancer 2004; 4:158-64.
18. Lorimore SA, McIlrath JM, Coates PJ, Wright EG. Chromosomal instability in unirradiated hemopoietic cells resulting from a delayed in vivo bystander effect of gamma radiation. Cancer Res 2005; 65:5668-73.
19. Wright EG, Coates PJ. Untargeted effects of ionizing radiation: implications for radiation pathology. Mutat Res 2006; 597:119-32.
20. Lorimore SA, Chrystal JA, Robinson JI, Coates PJ, Wright EG. Chromosomal instability in unirradiated hemaopoietic cells induced by macrophages exposed in vivo to ionizing radiation. Cancer Res 2008; 68: 8122-6.
21. Lorimore SA, Mukherjee D, Robinson JI, Chrystal JA, Wright EG. Long-lived inflammatory signaling in irradiated bone marrow is genome dependent. Cancer Res 2011; 71:6485-91.
22. Mukherjee D, Coates PJ, Lorimore SA, Wright EG. The in vivo expression of radiation-induced chromosomal instability has an inflammatory mechanism. Radiat Res 2012; 177:18-24.
23. Mole RH. Whole body irradiation; radiobiology or medicine? Br J Radiol 1953; 26:234-41.
24. Khan MA, Hill RP, Van Dyk J. Partial volume rat lung irradiation: an evaluation of early DNA damage. Int J Radiat Oncol Biol Phys 1998; 40:467-76.
25. Khan MA, Van Dyk J, Yeung IW, Hill RP. Partial volume rat lung irradiation; assessment of early DNA damage in different lung regions and effect of radical scavengers. Radiother Oncol 2003; 66:95-102.
26. Camphausen K, Moses MA, Menard C, Sproull M, Beecken WD,Folkman J, et al. Radiation abscopal antitumor effect is mediated through p53. Cancer Res 2003; 63:1990-3.
27. Koturbash I, Loree J, Kutanzi K, Koganow C, Pogribny I,Kovalchuk O. In vivo bystander effect: cranial X-irradiation leads to elevated DNA damage, altered cellular proliferation and apoptosis, and increased p53 levels in shielded spleen. Int J Radiat Oncol Biol Phys 2008; 70:554-62.
28. Mancuso M, Pasquali E, Leonardi S, Tanori M, Rebessi S, Di Majo V, et al. Oncogenic bystander radiation effects in Patched heterozygous mouse cerebellum. Proc Natl Acad Sci U S A 2008; 105:12445-50.
29. Mothersill C, Bristow RG, Harding SM, Smith RW, Mersov A,Seymour CB. A role for p53 in the response of bystander cells to receipt of medium borne signals from irradiated cells. Int J Radiat Biol 2011; 87:1120-5.
30. Burr KL, Robinson JI, Rastogi S, Boylan MT, Coates PJ, Lorimore SA, et al. Radiation-induced delayed bystander-type effects mediated by hemopoietic cells. Radiat Res 2010; 173:760-8.
31. Rastogi S, Coates PJ, Lorimore SA, Wright EG. Bystander-type effects mediated by long-lived inflammatory signaling in irradiated bone marrow. Radiat Res 2012; 177:244-50.
32. Watson GE, Pocock DA, Papworth D, Lorimore SA, Wright EG. In vivo chromosomal instability and transmissible aberrations in the progeny of hemopoieticstem cells induced by high- and low- LET radiations. Int J Radiat Biol 2001; 77:409-17.
33. Lorimore SA, Pragnell IB, Eckmann L, Wright EG. Synergistic interactions allow colony formation in vitro by murine hemopoieticstem cells. Leuk Res 1990; 14:481-9.
34. Krammer PH. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol 1999; 71:163-210.
35. Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 2003; 10:26-35.
36. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S. NS-398, a new anti-inflammatory agent selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994; 47:55-9.
37. Chen BC, Chang YS, Kang JC, Hsu MJ, Sheu JR, Chen TL, et al. Peptidoglycan induces nuclear factor-kappaB activation and cyclooxygenase-2 expression via Ras, Raf-1, and ERK in RAW 264.7 macrophages. J Biol Chem 2004; 279:20889-97.
38. Opferman JT. Life and death during hematopoietic differentiation. Curr Opin Immunol 2007; 19:497-502.
39. Metcalf D. Molecular control of blood cells. Harvard University Press; Cambridge MA; 1988.
40. Mothersill C, Seymour CB, Joiner MC. Relationship between radiation-induced low-dose hypersensitivity and the bystander effect. Radiat Res 2002; 157:526-32.
41. Zhang Y, Zhou J, Held KD, Redmond RW, Prise KM, Liber HL. Deficiencies of double-strand break repair factors and effects on mutagenesis in directly gamma-irradiated and medium-mediated bystander human lymphoblastoid cells. Radiat Res 2008; 169:197-206.
42. Azzam EI, de Toledo SM, Little JB. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc Natl Acad Sci U S A 2001; 98:473-8.
43. Cheok CF, Verma CS, Baselga J, Lane DP. Translating p53 into the clinic. Nat Rev Clin Oncol 2011; 8:25-37.
44. Peller S, Rotter V. TP53 in hematological cancer: low incidence of mutations with significant clinical relevance. Hum Mutat 2003; 21:277-84.